Adaptation of a developmental test to accommodate young children with low vision

Introduction: This study analyzed the effects of accommodations for children with low vision in the Griffiths Mental Development Scales – Extended Revised (GMDS-ER). Methods: The sample comprised 25 children with low vision and a chronological age between 28 and 76 months. There were two assessment moments: in the first the Griffiths Scales were administered according to the procedures described in the Manual; about two to four weeks later, a second assessment was performed with the same instrument, but now adapted for low vision. Results: The results indicated that there were some favorable differences in the use of item accommodations for children with low vision, including statistically significant improvements of scores in subscales A. Locomotor, C. Language, and E. Performance, as well as in the Full Scale. All children, except one, increased their Full Scale score; in the subscales, the number of children that increased their scores varied. The combination of different types of accommodations (materials, administration conditions, and success criteria) generated the best results. Still, many children increased their scores only with accommodations to materials (e.g., enhancement of contours; greater visual contrast). Discussion: The results demonstrated the importance of adapting developmental standardized tests for children with low vision. Future studies should increase sample size and control variables related to type of visual impairment. Implications for Practitioners: Test developers and test users should consider accommodations for young children with low vision. This way developmental level could be described more precisely and intervention could be better adjusted to the abilities of each child. Furthermore, a more accurate developmental assessment of effective child competencies and difficulties may be useful in terms of eligibility criteria for special education services

The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome

Factor H (fH) is essential for complement homeostasis in fluid-phase and on surfaces. Its two C-terminal domains (CCP 19-20) anchor fH to self surfaces where it prevents C3b amplification in a process requiring its N-terminal four domains. In atypical hemolytic uremic syndrome (aHUS), mutations clustering towards the C-terminus of fH may disrupt interactions with surface-associated C3b or polyanions and thereby diminish the ability of fH to regulate complement. To test this we compared a recombinant protein encompassing CCP 19-20 with sixteen mutants. The mutations had only very limited and localized effects on protein structure. While we found four aHUS-linked fH mutations that decreased binding to C3b and/or to heparin (a model compound for cell-surface polyanionic carbohydrates), we identified five aHUS-associated mutants with increased affinity for either or both ligands. Strikingly, these variable affinities for the individual ligands did not correlate with the extent to which all the aHUS-associated mutants were found to be impaired in a more physiological assay that measured their ability to inhibit cell surface complement functions of full-length fH. Taken together, our data suggest that disruption of a complex fH-self surface recognition process, involving a balance of affinities for protein and physiological carbohydrate ligands, predisposes to aHUS

Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil

Abstract\ud \ud \ud \ud Background\ud HBV genotype F is primarily found in indigenous populations from South America and is classified in four subgenotypes (F1 to F4). Subgenotype F2a is the most common in Brazil among genotype F cases. The aim of this study was to characterize HBV genotype F2a circulating in 16 patients from São Paulo, Brazil. Samples were collected between 2006 and 2012 and sent to Hospital Israelita Albert Einstein. A fragment of 1306 bp partially comprising HBsAg and DNA polymerase coding regions was amplified and sequenced. Viral sequences were genotyped by phylogenetic analysis using reference sequences from GenBank (n=198), including 80 classified as subgenotype F2a. Bayesian Markov chain Monte Carlo simulation implemented in BEAST v.1.5.4 was applied to obtain the best possible estimates using the model of nucleotide substitutions GTR+G+I.\ud \ud \ud \ud Findings\ud It were identified three groups of sequences of subgenotype F2a: 1) 10 sequences from São Paulo state; 2) 3 sequences from Rio de Janeiro and one from São Paulo states; 3) 8 sequences from the West Amazon Basin.\ud \ud \ud \ud Conclusions\ud These results showing for the first time the distribution of F2a subgenotype in Brazil. The spreading and the dynamic of subgenotype F2a in Brazil requires the study of a higher number of samples from different regions as it is unfold in almost all Brazilian populations studied so far. We cannot infer with certainty the origin of these different groups due to the lack of available sequences. Nevertheless, our data suggest that the common origin of these groups probably occurred a long time ago.This work has been supported by CNPq and by Fundação de Amparo à Pesquisa do Estado de São Paulo – FAPESP 2011/50562-0 and 2008/50461-6, HCFMUSP, FFM, Alves de Queiroz Family Fund for Research and IIRS-SBIBAE. These supported institutions provided the found to development the DNA amplification, sequencing and phylogenetic analysis

Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil

Abstract\ud \ud \ud \ud Background\ud HBV genotype F is primarily found in indigenous populations from South America and is classified in four subgenotypes (F1 to F4). Subgenotype F2a is the most common in Brazil among genotype F cases. The aim of this study was to characterize HBV genotype F2a circulating in 16 patients from São Paulo, Brazil. Samples were collected between 2006 and 2012 and sent to Hospital Israelita Albert Einstein. A fragment of 1306 bp partially comprising HBsAg and DNA polymerase coding regions was amplified and sequenced. Viral sequences were genotyped by phylogenetic analysis using reference sequences from GenBank (n=198), including 80 classified as subgenotype F2a. Bayesian Markov chain Monte Carlo simulation implemented in BEAST v.1.5.4 was applied to obtain the best possible estimates using the model of nucleotide substitutions GTR+G+I.\ud \ud \ud \ud Findings\ud It were identified three groups of sequences of subgenotype F2a: 1) 10 sequences from São Paulo state; 2) 3 sequences from Rio de Janeiro and one from São Paulo states; 3) 8 sequences from the West Amazon Basin.\ud \ud \ud \ud Conclusions\ud These results showing for the first time the distribution of F2a subgenotype in Brazil. The spreading and the dynamic of subgenotype F2a in Brazil requires the study of a higher number of samples from different regions as it is unfold in almost all Brazilian populations studied so far. We cannot infer with certainty the origin of these different groups due to the lack of available sequences. Nevertheless, our data suggest that the common origin of these groups probably occurred a long time ago.This work has been supported by CNPq and by Fundação de Amparo à Pesquisa do Estado de São Paulo – FAPESP 2011/50562-0 and 2008/50461-6, HCFMUSP, FFM, Alves de Queiroz Family Fund for Research and IIRS-SBIBAE. These supported institutions provided the found to development the DNA amplification, sequencing and phylogenetic analysis

CariesCare International adapted for the pandemic in children: Caries OUT multicentre single-group interventional study protocol

Fil: Martignon, Stefania. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Douglas, Gail V. A. University of Leeds. Dental Public Health. Dental Institute; United Kingdom.Fil: Cortes, Andrea. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Newton, J. Timothy. King’s College. Faculty of Dentistry. Oral and Craniofacial Sciences; United Kingdom.Fil: Pitts, Nigel B. King’s College. Faculty of Dentistry. Oral and Craniofacial Sciences; United Kingdom.Fil: Ávila, Viviana. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Usuga Vacca, Margarita. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Usuga Vacca, Margarita. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Gamboa, Luis F. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Deery, Christopher. University of Sheffield. School of Clinical Dentistry; United Kingdom.Fil: Abreu - Placeres, Ninoska. Universidad Iberoamericana. Biomaterials and Dentistry Research Center. Academic Research Department; República Dominicana.Fil: Bonifacio, Clarisa. Academic Center for Dentistry Amsterdam. Department of Pediatric Dentistry; Países Bajos.Background: Comprehensive caries care has shown effectiveness in controlling caries progression and improving health outcomes by controlling caries risk, preventing initial-caries lesions progression, and patient satisfaction. To date, the caries-progression control effectiveness of the patient-centred risk-based cariesCare International (CCI) system, derived from ICCMS™ for the practice (2019), remains unproven. With the onset of the COVID-19 pandemic a previously planned multi-centre RCT shifted to this “Caries OUT” study, aiming to assess in a single-intervention group in children, the caries-control effectiveness of CCI adapted for the pandemic with non-aerosols generating procedures (non-AGP) and reducing in-office time. Methods: In this 1-year multi-centre single-group interventional trial the adapted-CCI effectiveness will be assessed in one single group in terms of tooth-surface level caries progression control, and secondarily, individual-level caries progression control, children’s oral-health behaviour change, parents’ and dentists’ process acceptability, and costs exploration. A sample size of 258 3–5 and 6–8 years old patients was calculated after removing half from the previous RCT, allowing for a 25% dropout, including generally health children (27 per centre). The single-group intervention will be the adapted-CCI 4D-cycle caries care, with non-AGP and reduced in-office appointments’ time. A trained examiner per centre will conduct examinations at baseline, at 5–5.5 months (3 months after basic management), 8.5 and 12 months, assessing the child’s CCI caries risk and oral-health behaviour, visually staging and assessing carieslesions severity and activity without air-drying (ICDAS-merged Epi); fillings/sealants; missing/dental-sepsis teeth, and tooth symptoms, synthetizing together with parent and external-trained dental practitioner (DP) the patient- and tooth-surface level diagnoses and personalised care plan. DP will deliver the adapted-CCI caries care. Parents’ and dentists’ process acceptability will be assessed via Treatment-Evaluation-Inventory questionnaires, and costs in terms of number of appointments and activities. Twenty-one centres in 13 countries will participate. Discussion: The results of Caries OUT adapted for the pandemic will provide clinical data that could help support shifting the caries care in children towards individualised oral-health behaviour improvement and tooth-preserving care, improving health outcomes, and explore if the caries progression can be controlled during the pandemic by conducting non-AGP and reducing in-office time.publishedVersionFil: Martignon, Stefania. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Douglas, Gail V. A. University of Leeds. Dental Public Health. Dental Institute; United Kingdom.Fil: Cortes, Andrea. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Newton, J. Timothy. King’s College. Faculty of Dentistry. Oral and Craniofacial Sciences; United Kingdom.Fil: Pitts, Nigel B. King’s College. Faculty of Dentistry. Oral and Craniofacial Sciences; United Kingdom.Fil: Ávila, Viviana. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Usuga Vacca, Margarita. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Usuga Vacca, Margarita. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Gamboa, Luis F. Universidad El Bosque. Caries Research Unit. Research Department; Colombia.Fil: Deery, Christopher. University of Sheffield. School of Clinical Dentistry; United Kingdom.Fil: Abreu - Placeres, Ninoska. Universidad Iberoamericana. Biomaterials and Dentistry Research Center. Academic Research Department; República Dominicana.Fil: Bonifacio, Clarisa. Academic Center for Dentistry Amsterdam. Department of Pediatric Dentistry; Países Bajos.Otras Ciencias de la Salu

Weak lensing in generalized gravity theories

We extend the theory of weak gravitational lensing to cosmologies with generalized gravity, described in the Lagrangian by a generic function depending on the Ricci scalar and a nonminimal coupled scalar field. We work out the generalized Poisson equations relating the dynamics of the fluctuating components to the two gauge-invariant scalar gravitational potentials, fixing the contributions from the modified background expansion and fluctuations. We show how the lensing equation gets modified by the cosmic expansion as well as by the presence of anisotropic stress, which is non-null at the linear level both in scalar-tensor gravity and in theories where the gravitational Lagrangian term features a nonminimal dependence on the Ricci scalar. Starting from the geodesic deviation, we derive the generalized expressions for the shear tensor and projected lensing potential, encoding the spacetime variation of the effective gravitational constant and isolating the contribution of the anisotropic stress, which introduces a correction due to the spatial correlation between the gravitational potentials. Finally, we work out the expressions of the lensing convergence power spectrum as well as the correlation between the lensing potential and the integrated Sachs-Wolfe effect affecting cosmic microwave background total intensity and polarization anisotropies. To illustrate phenomenologically the effects, we work out approximate expressions for the quantities above in extended quintessence scenarios where the scalar field coupled to gravity plays the role of the dark energy

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload

BackgroundPulmonary arterial hypertension (PAH) is a progressive disease characterized by increased pulmonary artery pressure leading to right ventricular (RV) failure. While current PAH therapies improve patient outlook, they show limited benefit in attenuating RV dysfunction. Recent investigations demonstrated that the thromboxane (TX) A2 receptor (TP) antagonist NTP42 attenuates experimental PAH across key hemodynamic parameters in the lungs and heart. This study aimed to validate the efficacy of NTP42:KVA4, a novel oral formulation of NTP42 in clinical development, in preclinical models of PAH while also, critically, investigating its direct effects on RV dysfunction.MethodsThe effects of NTP42:KVA4 were evaluated in the monocrotaline (MCT) and pulmonary artery banding (PAB) models of PAH and RV dysfunction, respectively, and when compared with leading standard-of-care (SOC) PAH drugs. In addition, the expression of the TP, the target for NTP42, was investigated in cardiac tissue from several other related disease models, and from subjects with PAH and dilated cardiomyopathy (DCM).ResultsIn the MCT-PAH model, NTP42:KVA4 alleviated disease-induced changes in cardiopulmonary hemodynamics, pulmonary vascular remodeling, inflammation, and fibrosis, to a similar or greater extent than the PAH SOCs tested. In the PAB model, NTP42:KVA4 improved RV geometries and contractility, normalized RV stiffness, and significantly increased RV ejection fraction. In both models, NTP42:KVA4 promoted beneficial RV adaptation, decreasing cellular hypertrophy, and increasing vascularization. Notably, elevated expression of the TP target was observed both in RV tissue from these and related disease models, and in clinical RV specimens of PAH and DCM.ConclusionThis study shows that, through antagonism of TP signaling, NTP42:KVA4 attenuates experimental PAH pathophysiology, not only alleviating pulmonary pathologies but also reducing RV remodeling, promoting beneficial hypertrophy, and improving cardiac function. The findings suggest a direct cardioprotective effect for NTP42:KVA4, and its potential to be a disease-modifying therapy in PAH and other cardiac conditions

Envejecimiento de la población

•Actividades básicas de la vida diaria en personas mayores y factores asociados •Asociación entre depresión y posesión de mascotas en personas mayores •Calidad de vida en adultos mayores de Santiago aplicando el instrumento WHOQOL-BREF •Calidad de vida en usuarios con enfermedad de Parkinson, demencia y sus cuidadores, comuna de Vitacura •Caracterización de egresos hospitalarios de adultos mayores en Puerto Natales (2007-2009) •Comportamiento de las patologías incluidas como GES para el adulto mayor atendido en un Cesfam •Contribución de vitaminas y minerales a las ingestas recomendadas diarias en ancianos institucionalizados de Madrid •Estado de salud oral del paciente inscrito en el Programa de Visita Domiciliaria •Evaluación del programa de discapacidad severa en Casablanca con la matriz de marco lógico •Factores asociados a satisfacción vital en una cohorte de adultos mayores de Santiago, Chile •Pauta instrumental para la identificación de riesgos para el adulto mayor autovalente, en su vivienda •Perfil farmacológico del paciente geriátrico institucionalizado y posibles consecuencias en el deterioro cognitivo •Programa de cuidados paliativos y alivio del dolor en Puerto Natales •Rehabilitación mandibular implantoprotésica: efecto en calidad de vida relacionada con salud bucal en adultos mayores •Salud bucodental en adultos mayores autovalentes de la Región de Valparaíso •Transición epidemiológica y el estudio de carga de enfermedad en Brasi